Haemophilia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
HEMGENIX Group:
- You have been treated with the commercial (non-trial) version of a medicine called HEMGENIX.
- You have signed a consent form either up to 3 months before or within 6 months after receiving HEMGENIX, or within 6 months of the study starting at your location.
FIX Prophylaxis Group:
- You are an adult (18 years or older) with hemophilia B who is already enrolled in a registry called ATHN Transcends Hemophilia (or a similar registry) and are currently receiving regular preventive treatment with a clotting factor called FIX.
Who may not be able to join:
HEMGENIX Group:
- You received HEMGENIX as part of a clinical trial (rather than as a standard commercial treatment) — only people who received HEMGENIX outside of a clinical trial are eligible for this group.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Global Program Director, CSL Behring
Phone: +1 610-878-4697
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Bleeding Rate (all bleeds) - HEMGENIX Cohort
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.